Andrea Falleni’s Post

BioNTech Acquires InstaDeep BioNTech Transforms Healthcare with InstaDeep Acquisition 🔬 AI in Healthcare Innovation: BioNTech’s acquisition of InstaDeep signifies a major leap in AI-powered healthcare solutions. 🧬 Next-Gen Immunotherapies: Expect advancements in personalized treatments and vaccine development through AI. 🌐 Global Health Impact: This move could revolutionize how healthcare solutions are developed and delivered worldwide. 🤖 Leveraging Deep AI: The integration of DeepChain™ technology in drug discovery is a game-changer. 💊 Healthcare's AI Era: BioNTech and InstaDeep are at the forefront of AI-driven healthcare breakthroughs. #BioNTech #HealthcareAI #InstaDeep #MedicalTech #InnovationHealth

Next month, at Economist Impact, our CEO Thomas Clozel discusses one of today’s most exciting questions: What could AI achieve in medicine? At Owkin, we strive to lower the time from drug-development to patient impact. Thomas will explain why he believes that only companies with an end-to-end approach can achieve this. This conversation with Ewalina Barylska from Salve Medica, Andrew Elder from AlbionVC and Jhonatan Bringas Dimitriades, MD from Lapsi Health, will touch on how digitized hospitals can enable virtuous use of data, what draws tech investors to biopharma, and cross-modality use of biomarkers. At the cutting edge, Thomas will also talk about how foundation models will revolutionize the way we achieve precision medicine. More information at https://lnkd.in/e23x-_EA #AI #medicine #techbio #drugdevelopment #foundationmodels

Gen AI can transform many aspects of patient care in the constantly changing field of healthcare. Gen AI has a significant impact on a variety of medical research tasks, from improving drug discovery through simulation of molecular interactions to speeding up dataset analysis. With their assistance in risk assessment and pandemic preparedness, Gen AI's predictive models further improve healthcare readiness by enabling rapid responses that may save lives.    Furthermore, healthcare workers can concentrate more on providing excellent treatment because AI's automated capabilities reduce administrative tasks. Precision healthcare has undergone a significant transition with the introduction of personalized medicine as a cornerstone that integrates genomic data and lifestyle factors to customize treatment plans.    Join us as we explore how this conversation might improve patient outcomes and operational efficiency. Are you eager to explore the potential of Gen AI in healthcare? Get in touch with us to learn how our customized offerings enable businesses to use state-of-the-art Gen AI technology, promoting better patient care and operational efficiency. Together, let's establish!     #GenAI #HealthcareTechnology  

🚀 Researchers at Ohio State University have developed #CURE, an AI model that estimates drug treatment effects accurately without clinical trials! 🧬 📊 Trained on 3M+ de-identified health records, CURE surpasses 7 other AI models, improving prediction accuracy by 7-8%. 🔬 Aligning closely with clinical trial results, this AI showcases the potential to revolutionize drug testing, making it faster and less costly. 💡 #AIinHealthcare is advancing! CURE could significantly speed up new treatment discoveries, bypassing traditional clinical trials' costs and timelines. #Innovation #HealthTech

Discover how AI is revolutionising the clinical trial industry with Saurabh Jain on the AI Advantage Show, hosted by Richard Wray! Learn about TrialGen, TrialKey's AI-driven Clinical Trial Simulator, which predicts trial success with 90% accuracy using real-world data. Understand the critical role of AI in optimising trial design, patient recruitment, and phase predictions, setting new ethical standards in clinical research. Listen now: https://lnkd.in/gCXN8SJ7 Book a demo:https://lnkd.in/g9rJtUBm Marketing and investor enquiries: [email protected] #clinicaltrials #ai #medicalresearch #trialkey #drugdiscovery #healthtech #biotech #aitechnology

The future of healthcare is data-driven, personalized and continuously evolving, promising better outcomes and more proactive care. Generative AI is poised to play a pivotal role in this transformation, enhancing diagnostics, accelerating drug development and tailoring treatments. Explore the potential of Generative AI in Healthcare in our blog 👉  https://lnkd.in/eB8th5jh  #generativeAI #healthcare #efficiency #innovation

"[Boston Scientific] turned to a team of independent researchers to compare the outcomes of the EKOS technology with that of mechanical thrombectomy, using a novel approach to patient data from a startup named Truveta. “I thought, ‘Wow, it could be transformational to get real-world data from healthcare records,’” says Dr. Michael R. Jaff, chief medical officer for peripheral interventions at Boston Scientific. “It’s the Holy Grail.”" Read more about this peer-reviewed, first-of-its-kind research on pulmonary embolism treatments done with Truveta Data, via Fast Company: https://tr.vet/42KCDj4 #PulmonaryEmbolism #PulmonaryEmbolismTreatment #BostonScientific #HealthData #HealthTech #HealthInnovation #HealthAI #AI #Innovation #HealthcareData #HealthcareAI #HealthcareInnovation #MedicalData #MedicalAI #MedicalInnovation #MedTech #BigData

This panel discussion is sure to be insightful. Mark your calendars!

The Impact of AI in Life Sciences. Watch now https://lnkd.in/emyVkJgg our first Vistatec Life Sciences – In Focus webinar hosted by Maria Mateos. Explore the upcoming shifts in the biopharma industry, unveiling key trends and the impact on clinical trials. #Biopharma2024 #Vistatec #LifeSciences #Trends

Celebrating the Power of AI! Learn how our leaders envision GenAI shaping the future of life sciences, from breakthroughs in drug discovery to advancements in patient care and innovations in clinical trials. Join us in celebrating AI's impact. Shikha Singhal Gope Biswas #AIAppreciationDay #GenAI #Innovation #LifeSciences #ArtificialIntelligence #FutureOfWork